Terug
Dagbereik
€ 55,01
€ 56,88
52-Weeksbereik
€ 9,57
€ 76,76
Volume
1.868.416
50D / 200D Gem.
€ 63,61
/
€ 41,41
Vorige Slotkoers
€ 56,67
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4831,2 | 0,3 |
| P/B | 16,9 | 2,9 |
| ROE % | -0,5 | 3,7 |
| Net Margin % | -0,2 | 3,8 |
| Rev Growth 5Y % | 56,5 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 78,78
+40.0%
Low: € 35,00
High: € 110,00
Forward WPA
-€ 3,21
Omzet Sch.
450 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,01
€ 1,52 – € 4,65
|
1,6 B | 5 |
| FY2029 |
-€ 1,27
-€ 1,96 – -€ 0,64
|
890 M | 2 |
| FY2028 |
-€ 2,81
-€ 4,10 – -€ 1,10
|
550 M | 7 |
Belangrijkste Punten
Revenue grew 56,50% annually over 5 years — strong growth
Generating 156,89M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 23201,65%
Capital efficient — spends only 2,73% of revenue on capex
Interest coverage of 1,10× — tight debt servicing
Groei
Revenue Growth (5Y)
56,50%
Revenue (1Y)23258,15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-0,50%
ROIC8,86%
Net Margin-0,20%
Op. Margin11,86%
Veiligheid
Debt / Equity
0,79
Current Ratio4,86
Interest Coverage1,10
Waardering
P/E Ratio
-4831,15
P/B Ratio16,91
EV/EBITDA81,54
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23258,15% | Revenue Growth (3Y) | 85,62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 56,50% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 829,45M | Net Income (TTM) | -1,63M |
| ROE | -0,50% | ROA | -0,12% |
| Gross Margin | 97,12% | Operating Margin | 11,86% |
| Net Margin | -0,20% | Free Cash Flow (TTM) | 156,89M |
| ROIC | 8,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,79 | Current Ratio | 4,86 |
| Interest Coverage | 1,10 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4831,15 | P/B Ratio | 16,91 |
| P/S Ratio | 9,50 | PEG Ratio | 28,35 |
| EV/EBITDA | 81,54 | Dividend Yield | 0,00% |
| Market Cap | 7,88B | Enterprise Value | 8,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 829,45M | 3,55M | 240,74M | 243,23M | 138,29M |
| Net Income | -1,63M | -599,49M | -205,28M | -176,06M | -140,85M |
| EPS (Diluted) | -0,01 | -5,00 | -1,92 | -1,67 | -1,36 |
| Gross Profit | 805,52M | 3,55M | 240,74M | 243,23M | 138,29M |
| Operating Income | 98,35M | -601,08M | -205,00M | -178,51M | -149,04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,39B | 1,14B | 765,55M | 691,94M | 710,15M |
| Total Liabilities | 881,88M | 948,74M | 478,39M | 273,60M | 301,33M |
| Shareholders' Equity | 466,05M | 185,44M | 271,34M | 398,52M | 408,82M |
| Total Debt | 366,28M | 851,91M | 383,50M | 81,58M | 25,55M |
| Cash & Equivalents | 226,55M | 102,69M | 110,89M | 108,01M | 184,43M |
| Current Assets | 950,64M | 695,47M | 419,52M | 405,30M | 384,60M |
| Current Liabilities | 195,49M | 103,17M | 105,46M | 138,85M | 146,54M |